Found: 80
Select item for more details and to access through your institution.
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00993-0
- By:
- Publication type:
- Article
Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00886-8
- By:
- Publication type:
- Article
Universality and self-similarity in pinch-off of rods by bulk diffusion.
- Published in:
- Nature Physics, 2010, v. 6, n. 10, p. 796, doi. 10.1038/nphys1737
- By:
- Publication type:
- Article
Exploiting Automatic Image Processing and In-situ Transmission Electron Microscopy to Understand the Stability of Supported Nanoparticles.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
In situ Transmission Electron Microscopy for Data-driven Modeling of Nanoparticle Evolution.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
In situ Transmission Electron Microscopy for Data-driven Modeling of Nanoparticle Evolution.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Towards Real Time Quantitative Analysis of Supported Nanoparticle Ensemble Evolution Investigated by Environmental TEM.
- Published in:
- Microscopy & Microanalysis, 2019, p. 540, doi. 10.1017/S1431927618003197
- By:
- Publication type:
- Article
Towards Real Time Quantitative Analysis of Supported Nanoparticle Ensemble Evolution Investigated by Environmental TEM.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Solidification in 4D: from Dendrites to Eutectics.
- Published in:
- Microscopy & Microanalysis, 2017, v. 23, p. 320, doi. 10.1017/S1431927617002288
- By:
- Publication type:
- Article
Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study).
- Published in:
- Life (2075-1729), 2024, v. 14, n. 3, p. 384, doi. 10.3390/life14030384
- By:
- Publication type:
- Article
Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2227, doi. 10.1111/bjh.19386
- By:
- Publication type:
- Article
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 3, p. 355, doi. 10.1111/bjh.18432
- By:
- Publication type:
- Article
Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long‐term survival follow‐up from the Phase II study O‐12‐M1.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 6, p. 1105, doi. 10.1111/bjh.17302
- By:
- Publication type:
- Article
Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 1, p. 140, doi. 10.1111/bjh.15716
- By:
- Publication type:
- Article
A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 4, p. 547, doi. 10.1111/bjh.14708
- By:
- Publication type:
- Article
Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 3, p. 373, doi. 10.1111/bjh.13592
- By:
- Publication type:
- Article
Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A successful case of venetoclax-based therapy in relapsed/refractory secondary plasma cell leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1274, doi. 10.1177/1078155219895072
- By:
- Publication type:
- Article
Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation.
- Published in:
- Journal of Clinical Apheresis, 2021, v. 36, n. 4, p. 553, doi. 10.1002/jca.21892
- By:
- Publication type:
- Article
Hereditary chronic neutrophilic leukemia in a four‐generation family without transformation to acute leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 10, p. 1877, doi. 10.1002/ajh.27420
- By:
- Publication type:
- Article
A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202).
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. 1595, doi. 10.1002/ajh.26361
- By:
- Publication type:
- Article
Twin-mediated crystal growth: an enigma resolved.
- Published in:
- Scientific Reports, 2016, p. 28651, doi. 10.1038/srep28651
- By:
- Publication type:
- Article
Quadruplet Therapy May Be the New Frontline SOC in Multiple Myeloma.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 8, p. 317
- By:
- Publication type:
- Article
Materials integrity in microsystems: a framework for a petascale predictive-science-based multiscale modeling and simulation system.
- Published in:
- Computational Mechanics, 2008, v. 42, n. 4, p. 485, doi. 10.1007/s00466-008-0267-1
- By:
- Publication type:
- Article
Bone marrow Ki‐67 index is of prognostic value in newly diagnosed multiple myeloma.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 373, doi. 10.1111/ejh.14016
- By:
- Publication type:
- Article
Two-Phase Eutectic Growth in Al-Cu and Al-Cu-Ag.
- Published in:
- Metallurgical & Materials Transactions. Part A, 2018, v. 49, n. 5, p. 1692, doi. 10.1007/s11661-018-4488-4
- By:
- Publication type:
- Article
Coarsening With Low Pèclet Number Convective Transport Due to Sedimentation.
- Published in:
- Metallurgical & Materials Transactions. Part A, 2017, v. 48, n. 6, p. 2714, doi. 10.1007/s11661-017-3959-3
- By:
- Publication type:
- Article
The Morphological Evolution of Low Volume Fraction Tin Dendrites During Coarsening.
- Published in:
- Metallurgical & Materials Transactions. Part A, 2013, v. 44, n. 1, p. 406, doi. 10.1007/s11661-012-1380-5
- By:
- Publication type:
- Article
A qualitative study of patient and provider perspectives on using web-based pain coping skills training to treat persistent cancer pain.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Emerging Data on the Use of Anthracyclines in Combination with Bortezomib in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, p. S156
- By:
- Publication type:
- Article
Emerging Role of Novel Combinations for Induction Therapy in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 1, p. 33
- By:
- Publication type:
- Article
Front Cover: Site‐Specific Small Molecule Labeling of an Internal Loop in JC Polyomavirus Pentamers Using the π‐Clamp‐Mediated Cysteine Conjugation (ChemBioChem 21/2021).
- Published in:
- ChemBioChem, 2021, v. 22, n. 21, p. 2996, doi. 10.1002/cbic.202100317
- By:
- Publication type:
- Article
Site‐Specific Small Molecule Labeling of an Internal Loop in JC Polyomavirus Pentamers Using the π‐Clamp‐Mediated Cysteine Conjugation.
- Published in:
- ChemBioChem, 2021, v. 22, n. 21, p. 3037, doi. 10.1002/cbic.202100188
- By:
- Publication type:
- Article
Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 20, p. 6933, doi. 10.1002/cam4.4254
- By:
- Publication type:
- Article
Phase I Trial of the HSP90 Inhibitor PF-04929113 (SNX5422) in Adult Patients With Recurrent, Refractory Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 4, p. 385, doi. 10.1016/j.clml.2013.03.010
- By:
- Publication type:
- Article
Successful Use of Intrathecal Carboxypeptidase G2 for Intrathecal Methotrexate Overdose: A Case Study and Review of the Literature.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 166, doi. 10.1016/j.clml.2012.09.004
- By:
- Publication type:
- Article
Interference of Monoclonal Antibody Therapies with Serum Protein Electrophoresis Tests.
- Published in:
- Clinical Chemistry, 2010, v. 56, n. 12, p. 1897, doi. 10.1373/clinchem.2010.152116
- By:
- Publication type:
- Article
The mechanism of eutectic growth in highly anisotropic materials.
- Published in:
- Nature Communications, 2016, v. 7, n. 9, p. 12953, doi. 10.1038/ncomms12953
- By:
- Publication type:
- Article
Quantifying the Effects of Non‐Hydrostatic Stress on Multi‐Component Minerals.
- Published in:
- Journal of Geophysical Research. Solid Earth, 2022, v. 127, n. 9, p. 1, doi. 10.1029/2022JB025201
- By:
- Publication type:
- Article
A Clinical and Correlative Study of Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd) for Lenalidomide Refractory Multiple Myeloma in First Relapse.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 7, p. 535, doi. 10.1016/j.clml.2023.03.016
- By:
- Publication type:
- Article
Retrospective Review of Outcomes of Multiple Myeloma (MM) Patients With COVID-19 Infection (Two-Center Study).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 273, doi. 10.1016/j.clml.2023.01.006
- By:
- Publication type:
- Article
Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple Myeloma.
- Published in:
- 2023
- By:
- Publication type:
- journal article
P-180: Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in newly diagnosed Multiple Myeloma (NDMM): analysis of vascular thrombotic events (VTEs) in the GRIFFIN study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S135, doi. 10.1016/S2152-2650(21)02307-7
- By:
- Publication type:
- Article
Transition from Intravenous to Subcutaneous Daratumumab Formulation in Clinical Practice.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 7, p. 470, doi. 10.1016/j.clml.2021.02.014
- By:
- Publication type:
- Article
Thromboembolism Incidence and Risk Factors in Multiple Myeloma After First Exposure to Immunomodulatory Drug-Based Regimens.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Evaluation of Montelukast for the Prevention of Infusion-related Reactions With Daratumumab.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Frontline Therapy for Fit MM Patients Should Include an Antibody.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety and Cost Benefits of the Rapid Daratumumab Infusion Protocol.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Daratumumab + Lenalidomide, Bortezomib & Dexamethasone Improves Depth of Response in Transplant-eligible Newly Diagnosed Multiple Myeloma: GRIFFIN.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e353, doi. 10.1016/j.clml.2019.09.583
- By:
- Publication type:
- Article
Patient tolerability and Estimation of Direct/Productivity costs associated with rapid infusion of daratumumab.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e149, doi. 10.1016/j.clml.2019.09.248
- By:
- Publication type:
- Article